Prevalence of Latent and Active Tuberculosis Infection in Inflammatory Bowel Disease Patients Who Received Biological Treatment
Despite latent TB screening and prophylactic treatment, patients receiving TNF-α antagonists remain at risk of developing active TB, with a latent TB prevalence of 50.4% and an active TB incidence of 1.7%. These findings underscore the continued need for vigilance and robust TB monitoring strategies in this patient population.
Authors
- Tuğçe Eşkazan (ORCID: https://orcid.org/0000-0003-3008-1940)
- Gülen Hatemi (ORCID: https://orcid.org/0000-0002-1952-1135)
- İbrahim Hatemı (ORCID: https://orcid.org/0000-0002-8385-9253)
- Saida Dashdamirova
- Aykut Ferhat Celik
- Yusuf Ziya Erzin
Institutions
- Istanbul University-Cerrahpaşa (TR)
Publication Details
- Journal
- The Turkish Journal of Gastroenterology
- Published
- 2026-02-13
- DOI
- https://doi.org/10.5152/tjg.2026.25072
- Primary Topic
- Diagnosis and treatment of tuberculosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00